Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-27
2010-11-02
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C514S269000
Reexamination Certificate
active
07825117
ABSTRACT:
The present invention relates to prokineticin 1 receptor antagonists and methods of using the same to modulate intestine epithelial functions and to treat inflammation in the intestine in a mammal.
REFERENCES:
patent: 2003/0225075 (2003-12-01), Agarwal et al.
patent: 2004/0156842 (2004-08-01), Thompson et al.
patent: 2007/0049526 (2007-03-01), Thompson et al.
patent: WO 02/36625 (2002-05-01), None
patent: WO 2004/087054 (2004-10-01), None
patent: WO 2005/007164 (2005-01-01), None
International Search Report (Annex to Invitation to Pay Additional Fees dated Aug. 9, 2006) for corresponding Appln. No. PCT/US2006/009777.
Hornby Pamela J.
Mabus John R.
Palmer Jeffrey M.
Prouty Stephen M.
Wade Paul R.
LandOfFree
Methods of modulating intestine epithelial functions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulating intestine epithelial functions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating intestine epithelial functions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245472